Steven Russell, M.D., Ph.D., of the Mayo Clinic, and John Bell, Ph.D., of the University of Ottawa in Canada, each presented talks on how oncolytic viruses could be combined with vaccine approaches to produce more powerful
results than vaccines alone.
Not exact matches
Mr. Speaker, sector challenges affected the purchase of
vaccines,
resulting in lower
than targeted immunization coverage in the first half of 2017.
Initial
results suggested that people who had already been exposed to the adenovirus, and so had antibodies to it, before they received the trial
vaccine were more susceptible to HIV infection
than people who did not receive the
vaccine at all.
Simmonds suggests that if the «signature» of the envelope protein is as uniform as the early
results suggest, then
vaccines may be easier to design
than scientists had thought.
«Our
results demonstrate the substantial benefit of vaccinating during pregnancy rather
than waiting until after birth,» pediatrician and
vaccine researcher Nicola Klein and colleagues wrote online April 3 in Pediatrics.
The
results showed that children in the educational text message reminder group were significantly more likely to receive a second dose of influenza
vaccine (72.7 %)
than both those in the conventional text message reminder group (66.7 %) and written reminder - only group (57.1 %).
Influenza remains a major health problem in the United States,
resulting each year in an estimated 36,000 deaths and 200,000 hospitalizations.4 Those who have been shown to be at high risk for the complications of influenza infection are children 6 to 23 months of age; healthy persons 65 years of age or older; adults and children with chronic diseases, including asthma, heart and lung disease, and diabetes; residents of nursing homes and other long - term care facilities; and pregnant women.4 It is for this reason that the Centers for Disease Control and Prevention (CDC) has recommended that these groups, together with health care workers and others with direct patient - care responsibilities, should be given priority for influenza vaccination this season in the face of the current shortage.1 Other high - priority groups include children and teenagers 6 months to 18 years of age whose underlying medical condition requires the daily use of aspirin and household members and out - of - home caregivers of infants less
than 6 months old.1 Hence, in the case of
vaccine shortages
resulting either from the unanticipated loss of expected supplies or from the emergence of greater -
than - expected global influenza activity — such as pandemic influenza, which would prompt a greater demand for vaccination5 — the capability of extending existing
vaccine supplies by using alternative routes of vaccination that would require smaller doses could have important public health implications.
A new study has shown that boosting RV144 volunteers 6 - 8 years later with AIDSVAX B / E
vaccine resulted in higher immune responses
than were seen immediately after RV144.
Furthermore, over thirty scientists received specialised training on numerous aspects of
vaccine development, being provided with a thorough overview of the full
vaccine development process, and more
than twenty innovative scientific papers were published from TRANSVAC's research and activities (for more information see also tables below and: Geels, M. et al (2015): TRANSVAC research infrastructure —
Results and lessons learned from the European network of
vaccine research and development.
In rare cases (less
than 1 percent) the Lyme
vaccine causes an autoimmune response
resulting in kidney disease; retrievers are among the more susceptible breeds.
This provides a more accurate and better immune response
than just using dead virus, but occasionally these
vaccines can
result in a real infection (such as dogs who get kennel cough signs after getting a Bordetella
vaccine).
Giving
vaccines closer together
than every 2 weeks is actually likely to
result in less immunity, not more.